1. Short title and commencement.—(1) This Act may be called the National 2
[Institutes] of
Pharmaceutical Education and Research Act, 1998.
(2) It shall come into force on such date3
as the Central Government may, by notification in the
Official Gazette, appoint and different dates may be appointed for different provisions of this Act.
4
[2. Declaration of certain institutions as institutions of national importance.— (1) Whereas the
objects of the institutions mentioned in the Schedule, are such as to make them institutions of national
importance, it is hereby declared that each such Institute is an institution of national importance.
(2) It is hereby declared that every Institute established under sub-section (2A) of section 4, on and
after the commencement of the National Institute of Pharmaceutical Education and Research
(Amendment) Act, 2021 (43 of 2021), shall be an institution of national importance.]
3. Definitions.—In this Act, unless the context otherwise requires,—
5
[(a) “appointed day”, in relation to an Institute mentioned in column (3) of the Schedule, means
the date of its establishment as mentioned against it in column (4) of that Schedule;]
(b) “Board” means the Board of Governors of 6
[an Institute] constituted under sub-section (3) of
section 4;
(c) “Chairperson” means the Chairperson of 6
[an Institute] nominated under clause (a) of
sub-section (3) of section (4);
7
[(ca) “Council” means the Council established under sub-section (1) of section 30A;]
(d) “Dean” means the Dean of 6
[an Institute] appointed under section 17;
(e) “Director” means the Director of 6
[an Institute] appointed under section 16;
(f) “Fund” means the fund of 6
[an Institute] to be maintained under section 21;
8
[(g) “Institute” means any of the institutions mentioned in column (3) of the Schedule;
(ga) “member” means a member of the Council nominated or elected under sub-section (2) of
section 30A;
(gb) “prescribed” means prescribed by rules made under this Act;
(gc) “Schedule” means the Schedule to this Act;]
(h) “Senate” means the Senate of 6
[an Institute] referred to in section 13;
1. Subs. by Act 43 of 2021, s. 2 for Long title (w.e.f. 25-5-2022).
2. Subs. by s. 3, ibid., for “Institute” (w.e.f. 25-5-2022).
3. 8th July, 1998, vide notification No. S.O. 1412(E), dated 7th July, 1998, see Gazette of India, Extraordinary, Part II, sec. 3(ii).
4. Subs. by Act 43 of 2021, s. 4, for section 2 (w.e.f. 25-5-2022).
5. Subs. by s. 5, ibid., for clause (a) (w.e.f. 25-5-2022).
6. Subs. by s. 5, ibid., for “the Institute” (w.e.f. 25-5-2022).
7. Ins. by s. 5, ibid. (w.e.f. 25-5-2022).
8. Subs. by s. 5, ibid., for clause (g) (w.e.f. 25-5-2022).
4
(i) “Society” means the National Institute of Pharmaceutical Education and Research Society,
Sector-67, S.A.S. Nagar (Mohali), District Ropar, Punjab registered under the Societies Registration
Act, 1860 (21 of 1860);
(j) “Statutes” and “Ordinances” mean the Statutes and the Ordinances of 1
[an Institute] made
under this Act.